Physician profile
Allison E Marker
NPI 1134322217
$1,930.58
in general payments reported to CMS, 2019-2025
24 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $117 · 2021: $221 · 2022: $443 · 2023: $382 · 2024: $198 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $469.53 | 2019-2024 | |
| Astellas Pharma US INC | $327.80 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $159.07 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Conmed Corporation | $142.16 | 2022 | |
| Sumitomo Pharma America, INC. | $112.66 | 2023-2024 | Myfembree, Gemtesa |
| Pfizer INC. | $73.92 | 2019-2022 | |
| Roche Diagnostics Corporation | $72.92 | 2019 | |
| Aspira Women'S Health INC | $72.49 | 2021 | |
| Therapeuticsmd, INC. | $67.01 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.36 | 2019-2023 | |
| Ethicon US, LLC | $64.14 | 2021-2022 | |
| Organon LLC | $62.38 | 2022-2025 | Nexplanon |
| Avion Pharmaceuticals | $60.92 | 2019 | |
| Myovant Sciences INC. | $42.83 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.78 | 2023 | Xifaxan, Trulance |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $18.09 | 2019 | |
| Duchesnay USA Incorporated | $15.60 | 2019 | |
| Mayne Pharma Commercial LLC | $15.16 | 2022 | |
| Allergan, INC. | $14.01 | 2020 | |
| Lupin INC. | $13.80 | 2019 | |
| Baxter Healthcare | $13.53 | 2022 | |
| Agile Therapeutics, INC. | $13.07 | 2021 | |
| Olympus America INC. | $11.35 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Marker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.